(6-Hydroxy-2- (4-hydroxyphenyl) benzo[b]thiophen-3-yl) (4- (2- (piperidin-1-yl-d10) ethoxy) phenyl) methanone hydrochloride
(6-Hydroxy-2- (4-hydroxyphenyl) benzo[b]thiophen-3-yl) (4- (2- (piperidin-1-yl-d10) ethoxy) phenyl) methanone hydrochloride is deuterated labeled (6-Hydroxy-2- (4-hydroxyphenyl) benzo[b]thiophen-3-yl) (4- (2- (piperidin-1-yl.
Product Specifications
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1C(S2)=C(C(C3=CC=C(OCCN4C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C4([2H])[2H])C=C3)=O)C5=C2C=C(O)C=C5.Cl
Molecular Formula
C28H18D10ClNO4S
Molecular Weight
520.11
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog